What’s Behind a $211,680 CEO Sale at Vicor While AI Demand Drives 20% Revenue Growth?
Key Points Vicor’s CEO disposed of 700.0 shares at $302.40 per share, resulting in a transaction value of $211,680 on…
Category
Labor Market
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
Vertex Pharmaceuticals (NASDAQ:VRTX) said it has entered into a definitive agreement to acquire Crinetics Pharmaceuticals for $85 per share in…
What This Immunome Sale Means a Day Before a Big FDA Milestone
Key Points An Immunome insider sold 100,000 shares for $2.4 million based on weighted average prices on July 6, 2026…
Retiring with $1.2 Million? Here’s How to Avoid Running Out of Savings
Key Points As always, The Motley Fool cannot and does not provide personalized investing or financial advice. This information is…
1 Low-Cost Vanguard ETF Could Turn $300 per Month Into a $1 Million Portfolio. Here’s How.
Key Points Even modest monthly investments can grow into substantial sums, given the right strategy and enough time. For long-term…
Amazon Just Announced Shocking $25 Billion News. Should Investors Worry?
Key Points Amazon (NASDAQ: AMZN) is reported to have made a shocking decision in recent days. According to CNBC, it…